NovaBay Pharmaceuticals, Inc. Gains 43.98%
Wed, Jan 07, 2026 at 07:23 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) soared at $10.64, a gain of 44%. On Wed, Jan 07, 2026, NBY:NYSEMKT touched a New 2-Week High of $10.64. The stock appeared on our News Catalysts scanner on Fri, Dec 19, 2025 at 10:45 AM in the 'INVESTOR UPDATE' category. From Wed, Dec 24, 2025, the stock recorded 87.50% Up Days and 88.89% Green Days
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 76.14%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 60.1%
- Nuvve Holding Corp. (NVVE:NASDAQ), 59.55%
- Innovative Eyewear, Inc. (LUCY:NASDAQ), 47.46%
- Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ), 45.41%
- Century Therapeutics, Inc. (IPSC:NASDAQ), 44.44%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 43.98%
- Erasca, Inc. (ERAS:NASDAQ), 42.42%
- Momentus Inc. (MNTS:NASDAQ), 41.4%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 41.27%